Literature DB >> 6197362

Non-activated guinea-pig T cells and thymocytes express Ia antigens: FACS analysis with alloantibodies and monoclonal antibodies.

R Burger, I Scher, S O Sharrow, E M Shevach.   

Abstract

Conventional alloantisera and monoclonal antibodies to guinea-pig Ia antigens were used for analysis of Ia expression by guinea-pig T cells and thymocytes. Indirect immunofluorescent staining was performed with alloantisera or with ascitic fluid as a source of monoclonal antibody followed by flow microfluorometry analysis on the fluorescence activated cell sorter. About 80% of normal, non-activated peritoneal exudate T cells, lymph node T cells and thymocytes expressed Ia antigens. These data are therefore in contrast to studies with human or murine T cells where Ia antigens were shown to be expressed predominantly on activated but not on non-activated T cells. All the reactivity of the anti-Ia alloantisera for strain 2 T cells could be removed by absorption with an Ia-bearing B cell leukaemia, EN-L2C, but not by its Ia-negative variant, BZ-L2C. Thus, the Ia determinants identified on T and B cells are probably identical. One monoclonal antibody, 25E3, which had previously been shown by serologic analysis to react exclusively with an alloantigenic determinant of strain 2 Ia antigens displayed an unusual pattern of reactivity in that it clearly stained strain 13 thymocytes, but not mature strain 13 T or B lymphocytes. The significance of this possible expression of inappropriate Ia determinants by thymocytes remains unclear. This phenomenon might be associated with differentiation processes in the thymus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6197362      PMCID: PMC1454417     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

Review 1.  Monoclonal antibodies for analysis of the HLA system.

Authors:  F M Brodsky; P Parham; C J Barnstable; M J Crumpton; W F Bodmer
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

Review 2.  Monoclonal antibodies to Ia antigens from rat thymus: cross reactions with mouse and human and use in purification of rat Ia glycoproteins.

Authors:  W R McMaster; A F Williams
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  B-cell alloantigens on T lymphocytes.

Authors:  D L Mann; S O Sharrow
Journal:  Transplant Proc       Date:  1979-12       Impact factor: 1.066

4.  Further chemical characterization of guinea pig Ia molecules derived from the three major classes of immunocompetent cells.

Authors:  B D Schwartz; D Gordon; D W Thomas
Journal:  Mol Immunol       Date:  1979-01       Impact factor: 4.407

5.  Biochemical characterization of Ia alloantigens in guinea pigs. I. Synthesis of Ia antigens by subsets enriched for B cells, T cells, or macrophages.

Authors:  C R Lyons; M F Lipscomb; S F Schlossman; T F Tucker; J W Uhr
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

6.  Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression.

Authors:  E L Reinherz; P C Kung; J M Pesando; J Ritz; G Goldstein; S F Schlossman
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

7.  Cell surface appearance of unexpected host MHC determinants on thymocytes from radiation bone marrow chimeras.

Authors:  S O Sharrow; B J Mathieson; A Singer
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

8.  Monoclonal antibodies to guinea pig Ia antigens. I. Production, serologic, and immunochemical characterization.

Authors:  R Burger; L Clement; J Schroer; J Chiba; E M Shevach
Journal:  J Immunol       Date:  1981-01       Impact factor: 5.422

9.  Monoclonal antibodies to guinea pig Ia antigens. II. Effect on alloantigen-, antigen-, and mitogen-induced T lymphocyte proliferation in vitro.

Authors:  R Burger; E M Shevach
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

10.  Peripheral human T cells sensitized in mixed leukocyte culture synthesize and express Ia-like antigens.

Authors:  R L Evans; T J Faldetta; R E Humphreys; D M Pratt; E J Yunis; S F Schlossman
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  7 in total

1.  Selection of BoCD25 monoclonal antibodies by screening mouse L cells transfected with the bovine p55-interleukin-2 (IL-2) receptor gene.

Authors:  J Naessens; M Sileghem; N MacHugh; Y H Park; W C Davis; P Toye
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

2.  Tumour rejection after adoptive transfer of line-10-immune spleen cells is mediated by two T cell subpopulations.

Authors:  P A Steerenberg; E Geerse; W H De Jong; R Burger; R J Scheper; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Adoptive transfer of immunity to Treponema pallidum Nichols infection in inbred strain 2 and C4D guinea pigs.

Authors:  V Wicher; K Wicher; A Jakubowski; S M Nakeeb
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

4.  Major histocompatibility complex class II antigen expression on leucocyte subpopulations in the draining lymph node and tumour in the early phase of bacillus-Calmette-Guérin-induced tumour regression.

Authors:  P A Steerenberg; W H De Jong; E Geerse; A De Graaf; R J Scheper; W Den Otter; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

Review 5.  The guinea pig as a model of infectious diseases.

Authors:  Danielle J Padilla-Carlin; David N McMurray; Anthony J Hickey
Journal:  Comp Med       Date:  2008-08       Impact factor: 0.982

6.  Major-histocompatibility-complex-class-II-positive cells and interleukin-2-dependent proliferation of immune T cells are required to reject carcinoma cells in the guinea pig.

Authors:  P A Steerenberg; W H De Jong; E Geerse; A Beuvink; R J Scheper; W Den Otter; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

7.  Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-Guérin.

Authors:  P A Steerenberg; W H De Jong; E Geerse; B J Aleva; C M Besselink; B T Van Rens; V P Rutten; L G Poels; R J Scheper; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.